We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinical Observation |

Presymptomatic Neuromuscular Disorders Disclosed Following Statin Treatment

Georgios Tsivgoulis, MD; Konstantinos Spengos, MD; Nikolaos Karandreas, MD; Marios Panas, MD; Athina Kladi, MS; Panagiota Manta, MD
Arch Intern Med. 2006;166(14):1519-1524. doi:10.1001/archinte.166.14.1519.
Text Size: A A A
Published online


It is well recognized that statins affect muscular tissue adversely and that their use is associated with clinically important myositis, rhabdomyolysis, mild elevation of serum creatine kinase (CK) levels, myalgias, muscle weakness, muscle cramps, and persistent myalgias or serum CK level elevations after statin treatment is discontinued. The association between statins and the disclosure of presymptomatic metabolic myopathy is another underrated phenomenon related to statin therapy that was recently recognized in rare cases. The purpose of this report is to provide additional support for this association and to report other neuromuscular disorders that have also been seen following statin intake. The present case series illustrates that statins may act as unmasking agents in asymptomatic patients with a latent neuromuscular disorder. Thus, it may be postulated that statin intake may be a sufficient insult to precipitate neuromuscular symptoms and substantially increase muscle enzymes in presymptomatic patients with an abnormal neuromuscular substrate. In conclusion, muscular symptoms or increased serum CK levels persisting after statin treatment discontinuation should alert the clinician to pursue further diagnostic evaluations for the detection of potential underlying neuromuscular diseases.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?


Place holder to copy figure label and caption
Figure 1

. Muscle biopsy specimens and histochemical studies (original magnification for all ×500). A, Periodic acid-Schiff (PAS)-stained frozen section illustrates muscle fibers containing subsarcolemmal vacuoles (arrows) with PAS-positive material in case 2. B, Absent stain for the enzymatic activity of phosphorylase in muscle fibers of case 2; normal stain for the enzymatic activity of phosphorylase in the smooth muscle fibers of the vessel (arrows). C, Normal stain for the enzymatic activity of phosphorylase in muscle fibers of a control patient. D, Gomori trichrome stain demonstrating ragged red fibers (arrows) in case 3; the peripheral rim of red staining in some fibers represents aggregates of mitochondria. E, Succinate dehydrogenase (SDH) stain demonstrating intense activity in some fibers (ragged blue fibers) (arrows); these fibers correspond to the ragged red fibers on Gomori trichrome stain. F, Cytochrome oxidase (COX) stain demonstrating COX-negative fibers (arrows); these fibers correspond to the ragged blue fibers on SDH stain.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Atrophy of the tongue in case 4. The marked wasting of the large group of glossal muscles on each side has caused them to separate and form a longitudinal midline furrow.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

39 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles